Literature DB >> 12367616

Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats.

M Gulinello1, Q H Gong, S S Smith.   

Abstract

Withdrawal from the neurosteroid 3alpha,5alpha-allopregnanolone after chronic administration of progesterone increases anxiety in female rats and up-regulates the alpha4 subunit of the GABA(A) receptor (GABA(A)-R) in the hippocampus. We investigated if these phenomena would also occur in male rats. Progesterone withdrawal (PWD) induced higher alpha4 subunit expression in the hippocampus of both male and female rats, in association with increased anxiety (assessed in the elevated plus maze) comparable to effects previously reported. Because alpha4-containing GABA(A)-R are insensitive to the benzodiazepine (BDZ) lorazepam (LZM), and are positively modulated by flumazenil (FLU, a BDZ antagonist), we therefore tested the effects of these compounds following PWD. Using whole-cell patch clamp techniques, LZM-potentiation of GABA ((EC20))-gated current was markedly reduced in CA1 pyramidal cells of male rats undergoing PWD compared to controls, whereas FLU had no effect on GABA-gated current in control animals but increased it in PWD animals. Behaviorally, both male and female rats were significantly less sensitive to the anxiolytic effects of LZM. In contrast, FLU demonstrated significant anxiolytic effects following PWD. These data suggest that neurosteroid regulation of the alpha4 GABA(A)-R subunit may be a relevant mechanism underlying anxiety disorders, and that this phenomenon is not sex-specific.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367616      PMCID: PMC2887344          DOI: 10.1016/s0028-3908(02)00171-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  105 in total

1.  The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat.

Authors:  Y Akwa; R H Purdy; G F Koob; K T Britton
Journal:  Behav Brain Res       Date:  1999-12       Impact factor: 3.332

2.  Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal.

Authors:  L L Devaud; J M Fritschy; W Sieghart; A L Morrow
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

3.  Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.

Authors:  L Saxon; P Hjemdahl; A J Hiltunen; S Borg
Journal:  Psychopharmacology (Berl)       Date:  1997-05       Impact factor: 4.530

4.  Chronic cocaine differentially affects diazepam's anxiolytic and anticonvulsant actions. Relationship to GABA(A) receptor subunit expression.

Authors:  S M Lilly; E I Tietz
Journal:  Brain Res       Date:  2000-11-03       Impact factor: 3.252

5.  Chronic intermittent ethanol treatment in rats increases GABA(A) receptor alpha4-subunit expression: possible relevance to alcohol dependence.

Authors:  M Mahmoudi; M H Kang; N Tillakaratne; A J Tobin; R W Olsen
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

6.  Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat.

Authors:  M Gulinello; Q H Gong; X Li; S S Smith
Journal:  Brain Res       Date:  2001-08-10       Impact factor: 3.252

7.  Allopregnanolone inhibits learning in the Morris water maze.

Authors:  Inga Maj Johansson; Vita Birzniece; Charlotte Lindblad; Tommy Olsson; Torbjörn Bäckström
Journal:  Brain Res       Date:  2002-05-03       Impact factor: 3.252

8.  Electrophysiologic analysis of antidepressant drug effects on the GABA(A) receptor complex based upon antagonist-induced encephalographic power spectrum changes.

Authors:  M Matsubara; S Suzuki; K Miura; M Terashima; S Sugita; H Kimura; S Hatsuda; T Mori; H Murakami; T Hayashi; T Ohta; M Ohara
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

9.  Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

Authors:  I Sundström; A Andersson; S Nyberg; D Ashbrook; R H Purdy; T Bäckström
Journal:  Neuroendocrinology       Date:  1998-02       Impact factor: 4.914

10.  Chronic neurosteroid treatment decreases the efficacy of benzodiazepine ligands and neurosteroids at the gamma-aminobutyric acidA receptor complex in mammalian cortical neurons.

Authors:  R Yu; M K Ticku
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

View more
  25 in total

1.  Catamenial epilepsy: the elusive condition.

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2005 May-Jun       Impact factor: 7.500

2.  Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.

Authors:  Cynthia Neill Epperson; Brian Pittman; Kathryn Ann Czarkowski; Stephanie Stiklus; John Harrison Krystal; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2007-02-21       Impact factor: 7.853

Review 3.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

4.  Transcriptomic Analysis Reveals Sex-Dependent Expression Patterns in the Basolateral Amygdala of Dominant and Subordinate Animals After Acute Social Conflict.

Authors:  Katharine E McCann; David M Sinkiewicz; Anna M Rosenhauer; Linda Q Beach; Kim L Huhman
Journal:  Mol Neurobiol       Date:  2018-09-08       Impact factor: 5.590

5.  GABAA receptor currents in the dorsal motor nucleus of the vagus in females: influence of ovarian cycle and 5α-reductase inhibition.

Authors:  Erica L Littlejohn; Liliana Espinoza; Monica M Lopez; Bret N Smith; Carie R Boychuk
Journal:  J Neurophysiol       Date:  2019-10-09       Impact factor: 2.714

6.  Histone deacetylases mediate GABAA receptor expression, physiology, and behavioral maladaptations in rat models of alcohol dependence.

Authors:  John Peyton Bohnsack; Benjamin A Hughes; Todd K O'Buckley; Kamyra Edokpolor; Joyce Besheer; A Leslie Morrow
Journal:  Neuropsychopharmacology       Date:  2018-02-27       Impact factor: 7.853

Review 7.  Progesterone, reproduction, and psychiatric illness.

Authors:  Lindsay R Standeven; Katherine O McEvoy; Lauren M Osborne
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-18       Impact factor: 5.237

8.  A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.

Authors:  E Martín-García; M Pallarés
Journal:  Exp Brain Res       Date:  2008-07-30       Impact factor: 1.972

Review 9.  The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Authors:  Constance Guille; Susan Spencer; Idil Cavus; C Neill Epperson
Journal:  Epilepsy Behav       Date:  2008-03-17       Impact factor: 2.937

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.